Arrhythmia Patterns in Patients on Ibrutinib

Introduction: Ibrutinib, a Bruton's tyrosine kinase inhibitor (TKI) used primarily in the treatment of hematologic malignancies, has been associated with increased incidence of atrial fibrillation (AF), with limited data on its association with other tachyarrhythmias. There are limited reports...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazal, Muhammad, Kapoor, Ridhima, Cheng, Paul, Rogers, Albert J., Narayan, Sanjiv M., Wang, Paul, Witteles, Ronald M., Perino, Alexander C., Baykaner, Tina, Rhee, June-Wha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761892/
https://www.ncbi.nlm.nih.gov/pubmed/35047578
http://dx.doi.org/10.3389/fcvm.2021.792310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761892/
https://www.ncbi.nlm.nih.gov/pubmed/35047578
http://dx.doi.org/10.3389/fcvm.2021.792310

Ejemplares similares